Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Dec 14;32(12):E93–E99. doi: 10.1002/clc.20416

Patients with Metabolic Syndrome Have Prolonged Corrected QT Interval (QTc)

Weiju Li 1,4, Yongyi Bai 1,4, Kai Sun 2,3, Hao Xue 1,4, Yibo Wang 2,3, Xiaodong Song 2,3, Xiaohan Fan 1,4, Huijun Song 1,4, Yunfeng Han 1,4, Rutai Hui 1,2,3,4,✉
PMCID: PMC6653337  PMID: 20014212

Abstract

Background

Prolongation of corrected QT interval (QTc) increases morbidity and mortality and QTc has been found to be longer in patients with diabetes mellitus than in healthy controls. It is still inconclusive whether the metabolic syndrome results in QTc prolongation.

Hypothesis

We hypothesized that metabolic syndrome might contribute to risk of QTc prolongation. The hypothesis was tested in a large population.

Methods

A total of 5,815 individuals (men: 1,950, women: 3,865 aged 20–80 years) were enrolled. Metabolic syndrome was defined according to the revised third National Cholesterol Education Program Adult Treatment Panel (NCEP‐ATP III). QTc was calculated by using Bazett and Fridericia equations and the corrected JT interval (JTc) was derived by subtracting the QRS duration from the QTcB. All individuals had physical examinations, electrocardiograms, echocardiography, and blood tests.

Results

Individuals with metabolic syndrome had longer QTcs and JTc than those without metabolic syndrome (439.84 ms versus 430.90 ms in men, 456.37 ms versus 445.12 ms in women, respectively, p < 0.001 using Bazett formula). The more the number of abnormal metabolic parameters they had, the longer the QTcs and JTc they had. Trend analysis indicated that QTcB, QTcF, and JTc were significantly correlated to the number of abnormal metabolic parameters both in men and in women. After being adjusted for conventional risk factors, QTcB, QTcF, and JTc remained negatively associated with serum potassium concentration and positively associated with interventricular septal thickness.

Conclusions

Metabolic syndrome is a risk factor for prolonged QTc, which may further increase cardiovascular morbidity and mortality in the subjects with metabolic syndrome. Copyright © 2009 Wiley Periodicals, Inc.

Keywords: QTc, metabolic syndrome, risk factor

Full Text

The Full Text of this article is available as a PDF (116.5 KB).

References

  • 1. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D: Association between QT interval and coronary heart disease in middle‐aged and elderly men. The Zutphen Study. Circulation 1994; 90(2): 779–785. [DOI] [PubMed] [Google Scholar]
  • 2. Goldberg RJ, Bengtson J, Chen ZY, Anderson KM, Locati E, et al.: Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol 1991; 67(1): 55–58. [DOI] [PubMed] [Google Scholar]
  • 3. Rautaharju PM, Manolio TA, Psaty BM, Borhani NO, Furberg CD: Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol 1994; 73(13): 999–1002. [DOI] [PubMed] [Google Scholar]
  • 4. Nakanishi S, Yamada M, Hattori N, Suzuki G: Relation between QT duration and mortality in an elderly Japanese population. Am J Cardiol 2004; 93(9): 1182–1185. [DOI] [PubMed] [Google Scholar]
  • 5. Wong KY, McSwiggan S, Kennedy NS, Wong SY, Gavin A, et al.: Spectrum of cardiac abnormalities associated with long QT in stroke survivors. Heart 2005; 91(10): 1306–1310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Rana BS, Lim PO, Naas AA, Ogston SA, Newton RW, et al.: QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests. Heart 2005; 91(1): 44–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. SoRelle R: QTc interval and B‐type natriuretic peptide levels predict death in patients with advanced heart failure. Circulation 2003; 107(13): e9024–e9032. [DOI] [PubMed] [Google Scholar]
  • 8. Arildsen H, May O, Christiansen EH, Damsgaard EM: Increased QT dispersion in patients with insulin‐dependent diabetes mellitus. Int J Cardiol 1999; 71(3): 235–242. [DOI] [PubMed] [Google Scholar]
  • 9. Soydinc S, Davutoglu V, Akcay M: Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol 2006; 11(4): 313–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Pietrobelli A, Rothacker D, Gallagher D, Heymsfield SB: Electrocardiographic QTC interval: Short‐term weight loss effects. Int J Obes Relat Metab Disord 1997; 21(2): 110–114. [DOI] [PubMed] [Google Scholar]
  • 11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al.: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17): 2735–2752. [DOI] [PubMed] [Google Scholar]
  • 12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206–1252. [DOI] [PubMed] [Google Scholar]
  • 13. Rautaharju PM, Wolf HK, Eifler WJ, Blackburn H: A simple procedure for positioning precordial ECG and VCG electrodes using an electrode locator. J Electrocardiol 1976; 9(1): 35–40. [DOI] [PubMed] [Google Scholar]
  • 14. Cowan JC, Yusoff K, Moore M, Amos PA, Gold AE, et al.: Importance of lead selection in QT interval measurement. Am J Cardiol 1988; 61(1): 83–87. [DOI] [PubMed] [Google Scholar]
  • 15. Toivonen L: More light on QT interval measurement. Heart 2002; 87(3): 193–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Harris RI, Steare SE: A meta‐analysis of ECG data from healthy male volunteers: Diurnal and intra‐subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies. Eur J Clin Pharmacol 2006; 62(11): 893–903. [DOI] [PubMed] [Google Scholar]
  • 17. Banker J, Dizon J, Reiffel J: Effects of the ventricular activation sequence on the JT interval. Am J Cardiol 1997; 79(6): 816–819. [DOI] [PubMed] [Google Scholar]
  • 18. The assessment of the potential for QT interval prolongation by non‐cardiovascular medicinal products. London: Committee for Proprietary Medicinal Products 1997.
  • 19. Prineas RJ CR, Blackburn H.: The Minnesota Code Manual of Electrocardiographic Findings. Boston, MA: John Wright; 1982. 223–229. [Google Scholar]
  • 20. Tajik AJ, Seward JB, Hagler DJ, Mair DD, Lie JT: Two‐dimensional real‐time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc 1978; 53(5): 271–303. [PubMed] [Google Scholar]
  • 21. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, et al.: QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 1996; 45(3): 376–380. [DOI] [PubMed] [Google Scholar]
  • 22. Ferrannini E, Galvan AQ, Gastaldelli A, Camastra S, Sironi AM, et al.: Insulin: New roles for an ancient hormone. Eur J Clin Invest 1999; 29(10): 842–852. [DOI] [PubMed] [Google Scholar]
  • 23. Buja G, Miorelli M, Turrini P, Melacini P, Nava A: Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72(12): 973–976. [DOI] [PubMed] [Google Scholar]
  • 24. Grandinetti A, Seifried S, Mor J, Chang HK, Theriault AG: Prevalence and risk factors for prolonged QTc in a multiethnic cohort in rural Hawaii. Clin Biochem 2005; 38(2): 116–122. [DOI] [PubMed] [Google Scholar]
  • 25. Montague CT, O'Rahilly S: The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000; 49(6): 883–888. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES